Clinical Trials Logo

Clinical Trial Summary

Upper limb arterial disease is a rare condition compared to lower limb arterial disease. In the lower limb, chronic limb ischemia (CLI) is characterized by an intractable pain or an ulceration present for at least 2 weeks. Guidelines recommend to use Transcutaneous Oxygen pressure (TcPO2) measurement when a CLI is suspected to establish diagnostic with a threshold of 30 mmHg when ankle and toe systolic pressure are not available. In the upper limb, there is no guideline to define CLI. When there is a wound preventing finger pressure measurement, TcPO2 is theoretically indicated. However, there is neither standardized site to measure nor threshold value of TcPO2. The investigators hypothesized that normal TcPO2 may be different in the upper limb and that threshold value for CLI may also be different compared to lower limb. The investigators planned a study with two parts: 1. Prospective study of normal TcPO2 value in healthy volunteers 2. Retrospective analysis of patients with upper limb arterial disease to approach the TcPO2 threshold of CLI allowing healing in upper limb

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05192707
Study type Observational
Source Hospices Civils de Lyon
Contact Judith CATELLA, MD
Phone +33 472 11 77 91
Email [email protected]
Status Recruiting
Start date March 2022
Completion date March 2023

See also
  Status Clinical Trial Phase
Completed NCT02041169 - Lower Extremity Peripheral Arterial Disease and Exercise Ischemia N/A
Completed NCT01436435 - The Jetstream (JET) Post-market Registry Phase 4
Completed NCT01983449 - Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease Phase 4
Completed NCT03469349 - Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB Phase 3
Completed NCT00640770 - Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease Phase 4
Withdrawn NCT02531139 - The Effect of Blood Pressure on Cerebral Perfusion During Vascular Surgery N/A
Completed NCT00652418 - Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography Phase 2
Completed NCT02920125 - Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT. Phase 3
Completed NCT02273232 - Effects of Remote Ischemic Preconditioning on Moderate PVD Patients A Pilot Randomized Control Trial Phase 1
Completed NCT01952756 - Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD) Phase 4
Completed NCT01419418 - Patients' Perspectives of Factors That Support the Management of Peripheral Arterial Disease for Improved Outcomes N/A
Completed NCT02066740 - EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study N/A
Completed NCT01336101 - Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent N/A